ID

32923

Descrizione

Study ID: 107085 Clinical Study ID: GLP107085 Study Title: A Randomized, Double-blind, Parallel, Nested Crossover Study to Investigate the Effect of Albiglutide on Cardiac Repolarization (corrected QT Interval) Compared With Placebo in Healthy Male and Female Subjects: A Thorough ECG Study Employing Placebo, Albiglutide, and a Positive Control (Moxifloxacin) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01406262 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: albiglutide Trade Name: Tanzeum,Eperzan Study Indication: Diabetes Mellitus, Type 2

Keywords

versioni (1)
  1. 20/11/18 20/11/18 -
Titolare del copyright

GSK group of companies

Caricato su

20 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

The Effect of Albiglutide on Cardiac Repolarisation Compared with Placebo 107085

Inglese

Liver Event Form: General Data

1 moduli  
Administrative data
Descrizione

Administrative data

Study Name
Descrizione

Study Name

Tipo di dati

text

Site
Descrizione

Site

Tipo di dati

text

Subject
Descrizione

Subject

Tipo di dati

text

Visit Name
Descrizione

Visit Name

Tipo di dati

text

DCI Name/Shortname
Descrizione

DCI Name/Shortname

Tipo di dati

text

Status
Descrizione

Status

Tipo di dati

text

Doc#
Descrizione

Doc#

Tipo di dati

integer

Visit #
Descrizione

Visit #

Tipo di dati

float

Liver Events Assessment
Descrizione

Liver Events Assessment

Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
Descrizione

If YES, stop investigational product, complete date on Investigational Product form, contact GSK within 24 hours of occurrence, complete Liver Events Form and obtain the following test: -Blood sample for PK analysis, obtained within three half-lives (21 days) of last dose -Hepatitis A -Hepatitis B -Hepatitis C -Hepatitis E -Cytomegalovirus IgM antibody -EBV or if unavailabel, obtain heteropile antibody or monospot testing -CPK -LDH -Bilirubin fractionation, if bilirubin >=1.5xULN

Tipo di dati

boolean

Liver Event Description
Descrizione

Liver Event Description

Date of assessment
Descrizione

Date of assessment

Tipo di dati

date

AE/SAE reference number
Descrizione

AE/SAE reference number

Tipo di dati

text

Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
Descrizione

check all that apply

Tipo di dati

text

Other, specify
Descrizione

Other, specify

Tipo di dati

text

Is the subject age 55 or older?
Descrizione

Is the subject age 55 or older?

Tipo di dati

boolean

If female, is the subject pregnant?
Descrizione

If YES, ensure Pregnancy Notification Form has been completed.

Tipo di dati

text

Were any diagnostic tests of the liver or hepatobiliary system performed?
Descrizione

Were any diagnostic tests of the liver or hepatobiliary system performed?

Tipo di dati

boolean

If Yes, were the results normal?
Descrizione

If Yes, complete Liver Biopsy Form

Tipo di dati

boolean

Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Descrizione

If Yes, record on the appropriate Concomitant Medication form

Tipo di dati

boolean

Did the subject fast or undergo significant dietary change in the past week?
Descrizione

Did the subject fast or undergo significant dietary change in the past week?

Tipo di dati

boolean

Was a pharmacokinetic blood sample obtained?
Descrizione

An unscheduled PK blood sample must be obtained within three half-lives

Tipo di dati

boolean

If Yes, date of sample taken
Descrizione

If Yes, date of sample taken

Tipo di dati

date

If Yes, time of sample taken
Descrizione

If Yes, time of sample taken

Tipo di dati

time

If Yes, date of last investigational product dose prior to PK sample
Descrizione

If Yes, date of last investigational product dose prior to PK sample

Tipo di dati

date

If Yes, time of last investigational product dose prior to PK sample
Descrizione

If Yes, time of last investigational product dose prior to PK sample

Tipo di dati

time

Ritorna all'inizio della pagina

Similar models

Liver Event Form: General Data

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative data
Study Name
Item
Study Name
text
Site
Item
Site
text
Subject
Item
Subject
text
Visit Name
Item
Visit Name
text
DCI Name/Shortname
Item
DCI Name/Shortname
text
Status
Item
Status
text
Doc#
Item
Doc#
integer
Visit #
Item
Visit #
float
Item Group
Liver Events Assessment
Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
Item
Have liver chemistry results reached or exceeded protocol-defined stopping criteria?
boolean
Item Group
Liver Event Description
Date of assessment
Item
Date of assessment
date
AE/SAE reference number
Item
AE/SAE reference number
text
Item
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
text
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
Code List
Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
CL Item
ALT (alanine aminotransferase) (1)
CL Item
AST (aspartate aminotransferase) (2)
CL Item
Total bilirubin (3)
CL Item
Other (4)
Other, specify
Item
Other, specify
text
Is the subject age 55 or older?
Item
Is the subject age 55 or older?
boolean
Item
If female, is the subject pregnant?
text
If female, is the subject pregnant?
Code List
If female, is the subject pregnant?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Not Applicable (3)
Were any diagnostic tests of the liver or hepatobiliary system performed?
Item
Were any diagnostic tests of the liver or hepatobiliary system performed?
boolean
If Yes, were the results normal?
Item
If Yes, were the results normal?
boolean
Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Item
Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
Did the subject fast or undergo significant dietary change in the past week?
Item
Did the subject fast or undergo significant dietary change in the past week?
boolean
Was a pharmacokinetic blood sample obtained?
Item
Was a pharmacokinetic blood sample obtained?
boolean
If Yes, date of sample taken
Item
If Yes, date of sample taken
date
If Yes, time of sample taken
Item
If Yes, time of sample taken
time
If Yes, date of last investigational product dose prior to PK sample
Item
If Yes, date of last investigational product dose prior to PK sample
date
If Yes, time of last investigational product dose prior to PK sample
Item
If Yes, time of last investigational product dose prior to PK sample
time
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial